WallStreetZenWallStreetZen

NASDAQ: TSHA
Taysha Gene Therapies Inc Stock Ownership - Who owns Taysha Gene Therapies?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Taysha Gene Therapies Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sukumar NagendranPresident and Head of RD2025-12-01260,047$1.71
$444.68kBuy
Sukumar NagendranPresident and Head of RD2025-12-01260,047$4.51
$1.17MSell
Sukumar NagendranPresident and Head of RD2025-11-2839,953$1.71
$68.32kBuy
Sukumar NagendranPresident and Head of RD2025-11-2870,172$0.70
$49.05kBuy
Sukumar NagendranPresident and Head of RD2025-11-28110,125$4.75
$523.09kSell
Sukumar NagendranPresident and Head of RD2025-09-10200,000$3.23
$646.00kSell
Sukumar NagendranPresident and Head of RD2025-09-1041,150$0.70
$28.76kBuy
Sukumar NagendranPresident and Head of RD2025-08-2157,054$2.85
$162.60kSell
Kamran AlamCHIEF FINANCIAL OFFICER2025-08-2154,491$2.85
$155.30kSell
Paul B. Manning10% Owner2025-05-30750,000$2.75
$2.06MBuy

1 of 2

TSHA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TSHA insiders and whales buy or sell their stock.

TSHA Shareholders

What type of owners hold Taysha Gene Therapies Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rtw Investments LP8.89%24,354,291$129.32MInstitution
Ra Capital Management LP8.60%23,555,648$125.08MInstitution
Avoro Capital Advisors LLC7.92%21,700,000$115.23MInstitution
Morgan Stanley7.05%19,307,603$102.52MInstitution
Blackrock Inc5.97%16,364,861$86.90MInstitution
Fmr LLC5.33%14,593,412$77.49MInstitution
Goldman Sachs Group Inc4.89%13,383,708$71.07MInstitution
Vanguard Group Inc4.69%12,849,613$68.23MInstitution
Siren LLC4.02%11,014,737$58.49MInstitution
Octagon Capital Advisors LP3.31%9,067,500$48.15MInstitution

1 of 3

TSHA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TSHA89.69%10.31%Net BuyingNet Buying
ORKA22.87%77.13%Net BuyingNet Buying
PHVS89.05%0.00%
NRIX90.92%9.08%Net SellingNet Selling
INVA60.33%39.67%Net SellingNet Buying
View Top Biotech Stocks

Taysha Gene Therapies Stock Ownership FAQ

Who owns Taysha Gene Therapies?

Taysha Gene Therapies (NASDAQ: TSHA) is owned by 96.59% institutional shareholders, 11.11% Taysha Gene Therapies insiders, and 0.00% retail investors. Ra Session Ii is the largest individual Taysha Gene Therapies shareholder, owning 9.01M shares representing 3.29% of the company. Ra Session Ii's Taysha Gene Therapies shares are currently valued at $50.11M.

If you're new to stock investing, here's how to buy Taysha Gene Therapies stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.